Please try another search
Facebook, Inc. (NASDAQ:FB) has pulled the plug on its teens-only app, Lifestage nearly a year after it was launched. The app was designed to assist teenagers connect with their peers by creating a...
Orexigen Therapeutics, Inc (NASDAQ:OREX) reported adjusted loss of $1.82 per share in the second quarter of 2017, which was narrower than the Zacks Consensus Estimate of a loss of $2.40. Adjusted...
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) posted second-quarter 2017 loss of $1.78 per share, wider than both the Zacks Consensus Estimate of a loss of $1.52 and the year-ago loss of...
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) reported a loss of 13 cents in the second quarter of 2017, narrower than both the Zacks Consensus Estimate of a loss of 16 cents and the year-ago loss of 26...
Graphics chipmaker NVIDIA (NASDAQ:NVDA) is set to release second-quarter fiscal 2018 results on August 10 after market close. As it has been one of the hottest stocks this year, let’s take a...
On Thursday, August 10th, NVIDIA (NVDA) will release its second quarter earnings results after the bell. The company is a Zacks Rank 2 (Buy), and have a Value, Growth, and Momentum score of F. Dave...
Prothena Corporation plc (NASDAQ:PRTA) reported a loss of 46 cents per share in the second quarter of 2017, narrower than the year-ago loss of $1.18 and the Zacks Consensus Estimate loss of 89...
Endocyte, Inc. (NASDAQ:ECYT) reported a loss of 28 cents per share in second-quarter 2017, wider than the Zacks Consensus Estimate of a loss of 25 cents but narrower than the year-ago loss of 33...
Celldex Therapeutics, Inc. (NASDAQ:CLDX) incurred second-quarter 2017 loss of 23 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 25 cents as well as the year-ago...
Kite Pharma, Inc. (NASDAQ:KITE) reported narrower-than-expected loss in the second quarter of 2017 and beat estimates for sales. Shares of the biotech company rose 5.8% on Tuesday.In fact, this year...
McCormick & Company, Inc. (NYSE:MKC) has recently announced a public offering in regard to partly finance the acquisition of food division of Reckitt Benckiser Group plc, announced last month....
After 10 straight days of the Dow closing up — including nine straight all-time highs — investors may be forgiven that this robust bull market, on the heels of another successful earnings...
ARRIS International PLC (NASDAQ:ARRS) , leading customer premises equipment manufacturer for the cable TV industry, reportedly moved one step forward to complete its proposed acquisition of Ruckus...
Fossil Group Inc. (NASDAQ:FOSL) reported narrower-than-expected loss in the second quarter of fiscal 2017, while sales lagged the Zacks Consensus Estimate. Shares plummeted 21.9% in after-hours...
When considering valuation metrics, the obvious choice has always been Price-to-Earnings ratio as calculations based on earnings are easy and come in handy. However, Price-to-Sales has emerged as a...